Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention.
Zhou XD, Cai J, Targher G, Byrne CD, Shapiro MD, Sung KC, Somers VK, Chahal CAA, George J, Chen LL, Zhou Y, Zheng MH; CHESS-MAFLD consortium.
Zhou XD, et al. Among authors: byrne cd.
Cardiovasc Diabetol. 2022 Dec 3;21(1):270. doi: 10.1186/s12933-022-01697-0.
Cardiovasc Diabetol. 2022.
PMID: 36463192
Free PMC article.
Review.